Acute Myeloid Leukemia, Childhood

Search Trials
A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status:
Not yet recruiting
Last Changed:
Oct 22, 2021
First Changed:
Oct 14, 2021
Disease(s):
AML, Childhood
Intervention(s):
CD33*CD3 BsAb
Relapsed Pediatric AML to Determine the Safety and Efficacy of the PARP Inhibitor Talazoparib in Combination With Conventional Chemotherapy
Status:
Not yet recruiting
Last Changed:
Nov 1, 2021
First Changed:
Nov 1, 2021
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
TalazoparibTopotecanGemcitabine
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
Status:
Recruiting
Last Changed:
Dec 9, 2021
First Changed:
Feb 1, 2019
Disease(s):
Leukemia
Intervention(s):
VyxeosVenetoclax
Biomarkers in Tissue Samples From Patients With Acute Promyelocytic Leukemia
Status:
Completed
Last Changed:
Oct 2, 2015
First Changed:
Nov 2, 2010
Disease(s):
Leukemia
Intervention(s):
protein expression analysiswestern blottingflow cytometrylaboratory biomarker analysis
Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia
Status:
Completed
Last Changed:
Apr 17, 2014
First Changed:
Jan 13, 2006
Disease(s):
Leukemia
Intervention(s):
arsenic trioxidecytarabinedaunorubicin hydrochloridemercaptopurinemethotrexatetretinoin

Connect. Empower. Inspire.